Global powered surgical instruments market is estimated to be valued at USD 2.41 Bn in 2025 and is expected to reach USD 3.29 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.
To learn more about this report, Request sample copy
Global powered surgical instruments market is expected to witness prominent growth over the forecast period, owing to rising number of medical procedures globally due to growing geriatric population. The advancement in medical technologies has led to development of more advanced powered surgical tools with improved accuracy, efficacy and efficiency. Growing investments by key players to strengthen product portfolios through innovations can drive the market growth. However, high costs associated with powered instruments can hamper the market growth. Rising demand for minimally invasive surgeries and increasing product adoption across emerging nations can offer lucrative opportunities for the market growth.
Rising Prevalence of Chronic Diseases
Rising prevalence of chronic diseases can drive the market growth. Various chronic conditions such as cardiovascular diseases, diabetes, cancers are among the top causes of mortality as well as disability-adjusted life years lost worldwide. It is projected that chronic diseases accounted for almost three-quarters of all deaths globally in 2020. Aging population coupled with changing lifestyle factors have further contributed to high prevalence of chronic diseases. As chronic diseases often require surgical intervention for treatment, thus, rising chronic disease burden boosts demand for various surgical procedures. Powered surgical instruments have become an integral part of many such procedures ranging from minimally invasive surgeries to complex reconstructive therapies. Their precision and control has improved outcomes for conditions that previously required highly invasive open surgeries. This has significantly boosted the uptake of powered instruments among healthcare facilities and surgeries. For instance, according to the American Academy of Orthopedic Surgeons (AAOS) Annual Report 2021, approximately 2.24 million primary and revision hip and knee arthroplasty procedures had been conducted over the past eight years. In February 2021, approximately 1.71 billion individuals globally were affected by musculoskeletal conditions. Growing prevalence of osteoporosis and osteoarthritis, rising incidents of road accidents and sports injuries, and an aging population can boost the number of procedures performed, contributing to market growth.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients